About Meghan Shea
Meghan is a key member of the Investments Team. As an Associate, she drives the investment process for potential opportunities that align with Rev1 sectors of interest in life sciences, and also assists in managing Rev1’s growing portfolio of life sciences companies and life sciences-focused investment funds, including Catalyst Fund III.
Meghan also works closely with our partners Nationwide Children’s Hospital and The Ohio State University to identify life sciences technologies with strong commercial potential that could become new startup companies. As a member of the investments team, Meghan also assists in the review of investment opportunities across all of Rev1’s active investment funds.
Among her professional accomplishments and extensive experience, Meghan previously worked as a Life Sciences Strategy Consultant in the Global Pharma space. Prior to her full-time career, she held other positions in pharma, including discovery research at Merck and as a sales representative at Eli Lilly.
Meghan holds a B.S. in Chemistry with a minor in Pharmaceutical Science from The Ohio State University. In her spare time, she enjoys golfing, reading, and being a dog mom to a Brittany Spaniel.
